BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  Destaco Introduces Tolerance Compensation Clamp Series

  Innovative clamping solution streamlines demanding welding and assembly applications in the automotive, aircraft and consumer goods industries

  September 28, 2018

   · 

  3 min read
• BioCapital

  SCRS Announces Global Summit Site Tank Finalists

  Today the Society for Clinical Research Sites (SCRS) announced the finalists for the 2018 Site Tank.

  September 28, 2018

   · 

  1 min read
• 

  Business

  As Diabetes Market Competition Heats up, Novo Nordisk to Cut 250 Jobs in U.S.

  Earlier this month, Novo Nordisk announced it was laying off 400 staffers in Denmark and China. Today, Reuters reports that the Danish company plans to lay off about 250 people in the United States.

  September 28, 2018

   · 

  3 min read

   · 

  Mark Terry
• Pharm Country

  New Cell Assay Service by Reaction Biology and Promega Will Allow More Researchers to Better Prioritize Compounds Earlier

  A new cell based profiling service for drug discovery announced by Reaction Biology Corporation (RBC), a premier provider of drug discovery services, and Promega Corporation, a worldwide leader in the supply of life science products, will allow more researchers to better prioritize compounds earlier.

  September 28, 2018

   · 

  2 min read
• Drug Development

  Allergy Therapeutics plc (“Allergy Therapeutics” or the “Group”) Preliminary Results

  Allergy Therapeutics plc today announces preliminary results for the year ended 30 June 2018.

  September 28, 2018

   · 

  3 min read
• Minoryx Therapeutics raises €21.3M in Series B funding round

  New investment will allow indication expansion of Minoryx’s lead compound, MIN-102

  September 28, 2018

   · 

  6 min read
• 

  Business

  Movers and Shakers Oct. 1

  Here’s a look at who shook things up in the world of pharma and biotech this week.

  September 28, 2018

   · 

  4 min read

   · 

  Alex Keown
• Pharm Country

  VIDEO: Matinas Biopharma’s (NYSE:MTNB) Jerome Jabbour and Prescription Omega-3 for Potential Cardio-Vascular Disease Remediation

  Join Ellis Martin for a conversation with Jerome Jabbour, CEO and Director of Matinas Biopharma

  September 28, 2018

   · 

  2 min read
• Policy

  ADVANCED BIFURCATION SYSTEMS GRANTED FOUR ADDITIONAL PATENTS

  Advanced Bifurcation Systems today announced that the Company has been granted four additional patents, three in the U.S. and one in Europe.

  September 28, 2018

   · 

  1 min read
• Business

  GeoVax Awarded $2.4 Million from U.S. Department of Defense to Advance Lassa Fever Vaccine

  GeoVax Labs, Inc. announced today that the U.S. Department of Defense (DoD) has awarded the Company a $2,442,307 cooperative agreement in supportof its novel Lassa Fever (LF) vaccine development program.

  September 28, 2018

   · 

  7 min read